Next-Generation Sequencing Supports Targeted Antibiotic Treatment for Culture Negative Orthopedic Infections

Area of Science:

• Infectious Diseases
• Microbiology
• Genomics

Background:

• Diagnosing orthopedic implant-associated infections, particularly peri-prosthetic joint infections (PJI), is often hindered by the low sensitivity of traditional culture methods, leading to culture-negative results.
• A significant percentage of orthopedic infections remain culture-negative, limiting the effective management and targeted therapy for patients.
• Current microbiological techniques frequently fall short of expectations in providing clinically relevant information for these complex infections.

Approach:

• This review explores the application and advantages of newer diagnostic technologies, focusing on next-generation sequencing (NGS).
• NGS is presented as a molecular diagnostic tool with the potential to enhance the diagnostic yield compared to conventional methods.
• The review discusses the integration of molecular diagnostics into clinical practice for improved pathogen identification.

Key Points:

• Next-generation sequencing (NGS) demonstrates significant potential to improve pathogen detection rates in orthopedic infections.
• Molecular diagnostics, such as NGS, can provide crucial information about infective organisms, surpassing the limitations of traditional cultures.
• The application of NGS is particularly beneficial in managing culture-negative peri-prosthetic joint infections (PJI).

Conclusions:

• Next-generation sequencing (NGS) is a valuable tool for diagnosing challenging orthopedic implant-associated infections, especially PJIs.
• Implementing NGS can lead to more accurate diagnoses and facilitate targeted antimicrobial therapy.
• The advancement of molecular diagnostics is crucial for overcoming the limitations of conventional methods in infectious disease diagnosis.